Braveheart Bio, Inc. (BRVE) has 14 SEC Form 4 insider filings on record in the last 90 days. That includes 10 insider purchases totalling $159.0M. Most recent filing: Aug. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 11, 2026 filed Aug. 7, 2026 | AH Bio Fund IV, L.P. 10% Owner | +$19,800,000 | 50,232,420 | — | No | |
|
|
||||||
| Aug. 11, 2026 filed Aug. 7, 2026 | Chimovits Erez Director | +$34,920,000 | 51,072,420 | — | No | |
|
|
||||||
| Aug. 11, 2026 filed Aug. 7, 2026 | ORBIMED ADVISORS LLC Director | +$34,920,000 | 51,072,420 | — | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 7, 2026 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% Owner | $0 | 39,920,091 | — | No | |
|
|
||||||
| Aug. 7, 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A. 10% Owner | +$64,800,000 | 95,723,287 | — | No | |
|
|
||||||
Showing the 5 most recent of 14 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free